OSTEOSARCOMA RECURRENT
Clinical trials for OSTEOSARCOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA RECURRENT trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough bone cancers: experimental drug trial opens
Disease control Recruiting nowThis early-stage study is testing a new drug called tegavivint, combined with an existing chemotherapy (gemcitabine), for people whose osteosarcoma (a type of bone cancer) has come back or stopped responding to standard treatments. The main goal is to find the safest and most eff…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with tough cancers: Two-Drug attack enters trial
Disease control Recruiting nowThis study is testing a new oral drug, AMXT 1501, combined with an existing drug called DFMO, for children and young adults with aggressive cancers that have come back or didn't respond to standard treatments. The first part aims to find a safe dose, and the second part will comp…
Matched conditions: OSTEOSARCOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC